✦ LIBER ✦

Development of a new in vitro model for the study of benign prostatic hyperplasia

✍ Scribed by Fouad K. Habib; Margaret Ross; Colin W. Bayne

Publisher: John Wiley and Sons
Year: 2000
Tongue: English
Weight: 669 KB
Volume: 45
Category: Article
ISSN: 0270-4137
DOI: 10.1002/1097-0045(2000)45:9+<15::aid-pros4>3.0.co;2-e

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Indications for treatment of benign pros

Indications for treatment of benign prostatic hyperplasia. The American Urological Association Study

✍ Abraham T. K. Cockett; Michael J. Barry; H. Logan Holtgrewe; Stephen Sihelnick; 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 326 KB 👁 2 views

A study of the efficacy and safety of tr

A study of the efficacy and safety of transurethral needle ablation (TUNA®) treatment for benign prostatic hyperplasia

✍ R. J. Millard; L. M. Harewood; K. Tamaddon 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 777 KB

An improved synthesis of enantiomericall

An improved synthesis of enantiomerically pure RWJ 69442, a development candidate for the treatment of benign prostatic hyperplasia

✍ Gee-Hong Kuo; Catherine Prouty; William V. Murray; Rekha D. Shah 📂 Article 📅 2001 🏛 Journal of Heterocyclic Chemistry 🌐 English ⚖ 39 KB

## Abstract This report describes an improved synthesis of enantiomerically pure (__S__)‐2‐[4‐(Dimethylamino)phenyl]‐2,3‐dihydro‐__N__‐[2‐hydroxy‐3‐[4‐[2‐(1‐methylethoxy)‐phenyl]‐1‐piperazinyl]propyl]‐1,3‐dioxo‐1__H__‐isoindole‐5‐carboxamide (RWJ 69442), a potent and selective α~la~‐adrenergic rece

Mouse prostate reconstitution model syst

Mouse prostate reconstitution model system: A series of in vivo and in vitro models for benign and malignant prostatic disease

✍ Timothy C. Thompson; Terry L. Timme; Sang Hee Park; Guang Yang; Chengzhen Ren 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 337 KB 👁 2 views

Urodynamic effects of silodosin, a new α

Urodynamic effects of silodosin, a new α1A-adrenoceptor selective antagonist, for the treatment of benign prostatic hyperplasia

✍ Tomonori Yamanishi; Tomoya Mizuno; Katsuhisa Tatsumiya; Miho Watanabe; Takao Kam 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 109 KB

## Aims: To investigate urodynamically the effects of silodosin, a new alpha(1a)-adrenoceptor-selective antagonist, in the treatment of benign prostatic hyperplasia (bph). ## Methods: Thirty six male patients with bph (69.9 +/- 7.3 years), who were referred as candidates for surgery, were treated

Prostate carcinoma risk subsequent to di

Prostate carcinoma risk subsequent to diagnosis of benign prostatic hyperplasia : A population-based cohort study in Sweden

✍ Anand P. Chokkalingam; Olof Nyrén; Jan-Erik Johansson; Gloria Gridley; Joseph K. 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 91 KB 👁 1 views

## Abstract ## BACKGROUND Pathologically, benign prostatic hyperplasia (BPH) is not considered a precursor for prostate carcinoma. However, because the two conditions share not only a similar hormonal environment within the prostate but also several common risk factors, it is possible that men wit